News | June 08, 2024
GSK acquires oligonucleotide drug startup Elsie
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
Further strengthens BaseLaunch's global pharma industry partnerships
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
Around 7% of the Indian population suffers from IBS
The demand in Africa for COVID-19 vaccines has declined
Subscribe To Our Newsletter & Stay Updated
